Herscu, Paul
Handen, Benjamin L.
Arnold, L. Eugene
Snape, Michael F.
Bregman, Joel D.
Ginsberg, Lawrence
Hendren, Robert
Kolevzon, Alexander
Melmed, Raun
Mintz, Mark
Minshew, Nancy
Sikich, Linmarie
Attalla, Ashraf
King, Brian
Owley, Thomas
Childress, Ann
Chugani, Harry
Frazier, Jean
Cartwright, Charles
Murphy, Tanya
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder
https://doi.org/10.1007/s10803-019-04120-y
Funding for this research was provided by:
Neuropharm PLC
Article History
First Online: 2 July 2019
Compliance with Ethical Standards
:
: Benjamin L. Handen, PhD: Research Funding: Roche, Eli Lilly,Curemark, Eisai Inc, Autism Speaks, NIA, NIMH, NICHD. L. Eugene Arnold, MD: Research Funding, Advisory Boards, Consultation: Forest, Eli Lilly, Noven, Roche, Shire, Supernus, YoungLiving, NIH, Autism Speaks, Pfizer, Tris Pharma, and Waypoint; Arbor, Ironshore, Otsuka, Seaside Therapeutics. Mark Mintz, MD: Research Funding, Advisory Boards, Consultation: Aquestive Therapeutics, Curemark, Eisai Inc., Impax Laboratories, Neurim Pharmaceuticals, Nuvelution Pharma Inc., PhenoSolve, Sunovion, and Teva, NeuroNeeds, Philips-Electrical Geodesics contracted through the Center for Neurological and Neurodevelopmental Health (CNNH NeuroHealth). Expert witness in various litigation and mitigation cases (contracted through CNNH NeuroHealth) and with Philips-Electrical Geodesics (contracted through CNNH NeuroHealth). Dr. Mintz is Chief Medical Officer, Owner and Founder of CNNH and CRCNJ; Board Member of CNNH Management, Inc.; and President and Founder of NeurAbilities, a 501(3)c public charity. Linmarie Sikich, MD: Research Funding, Advisory Boards,: NICHD, Marcus Foundation, Roche, Janssen, Sunovion, Curemark, Neuren Pharmaceuticals. Robert Hendren, DO: Research Funding, Advisory Boards: Curemark, Roche, Shire, Sunovion, BioMarin, Axial Therapeutics, Janssen. Alexander Kolevzon, MD: Research Funding, Consultation: AMO Pharma, Ovid Therapeutics, Sema4, LabCorp, 5AM Ventures, Takeda. Ann Childress, MD: Research Funding, Advisory Boards, Consultation, Speakers Bureau: Lundbeck, Pearson, Alcobra, Arbor, Eli Lilly, Ironshore, Forest Laboratories, Aevi Genomic Medicine, Neos Therapeutics, Neurovance, Otsuka America Pharmaceutical, Pfizer, Purdue, Noven, Shire, Akili, Cingulate, Rhodes, Sunovion, Tris, KemPharm, Supernus, U.S. Food & Drug Administration. Jean Frazier, MD: Research Funding: Roche, Fulcrum Therapeutics, Janssen, Neuren Pharmaceuticals, SyneuRx,NICHD, NIMH, Lawrence Ginsberg, MD: Research Funding, Consultation: Abbott Labs, Hoechst Marrion Roussel, Pfizer, Actavis, Intracellular Therapeutics, Purdue Pharma Canada, Aevi Genomic Medicine, Ironshore Pharmaceuticals, Sanofi-Adventis, Alkermees, Johnson & Johnson, Scherring-Plough, Allergan, Eli Lilly, Seaside Therapeutics, AstraZeneca, McNeil, Sepracor, Axsome Therapeutics, Medgenics, Shinionogi, Biohaven Pharmaceuticals, Neos, Shire, Bristol-Myers-Squibb, Neurocrine Bioscience, Sunovion, Cephalon, Neuropharm Ltd., Supernus, Coronado Biosciences, Novartis Takeda, Cyberonics, Organon Teva, Evidera pharmaceuticals, OrthoMcNeilJansen, UCB Pharma, Finch Therapeutics, Otsuka Maryland Research, Validus, Forest Labs, Pamlab, Wyeth, GSK, Angelini Labopharm, AstraZeneca, Dey, Janssen, Jaymac, Jazz, Lundbeck, Merck, Noven, Otsuka, Pamlab, PGHealth, Sanofi-Aventis, Shionogi, Validus, Wyeth. Michael Shape, PhD; Joel Bergman, MD; Bryan King, MD; Nancy Minshew, MD; Ruan Melmed, MD; Harry Chugani, MD; Charles Cartwright, MD; Ashraf Attalla, MD; and Tanya Murphy, MD, MS have no conflicts of interest to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and wit the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from the parents/guardians of all individual participants included in the study.